Up-regulation of IL-33 expression in various types of murine cells by IL-3 and IL-4

Cytokine

Volumn 58, Issue 2, 2012, Pages 267-273

  Zhao, Wei Hua ^a   Hu, Zhi Qing ^a  

^a SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fibroblasts; IL 3; IL 33 intracrine; IL 4; Macrophages

Indexed keywords

CYTOKINE; DNA; INTERLEUKIN 3; INTERLEUKIN 33; INTERLEUKIN 4; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL POPULATION; CELL SPECIFICITY; CELL TYPE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST; IMMUNOREGULATION; MACROPHAGE; MAST CELL; MOUSE; NONHUMAN; PERITONEAL EXUDATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; TARGET CELL; UPREGULATION;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INTERLEUKIN-3; INTERLEUKIN-4; INTERLEUKINS; IONOMYCIN; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

MURINAE; MUS;

EID: 84859215601     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.01.019     Document Type: Article

References (45)

1. Baekkevold E.S., Roussigné M., Yamanaka T., Johansen F.E., Jahnsen F.L., Amalric F., et al. Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003, 163:69-79.
2. Carriere V., Roussel L., Ortega N., Lacorre D.A., Americh L., Aguilar L., et al. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci USA 2007, 104:282-287.
3. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
4. Smithgall M.D., Comeau M.R., Yoon B.R., Kaufman D., Armitage R., Smith D.E. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 2008, 20:1019-1030.
5. Kakkar R., Lee R.T. The IL-33/ST2 pathway: therapeutic target and novel biomarker. Nat Rev Drug Discov 2008, 7:827-840.
6. H2-type immune responses initiated and amplified?. Nat Rev Immunol 2010, 10:225-235.
7. Allakhverdi Z., Smith D.E., Comeau M.R., Delespesse G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007, 179:2051-2054.
8. Xu D., Jiang H.R., Kewin P., Li Y., Mu R., Fraser A.R., et al. IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA 2008, 105:10913-10918.
9. Suzukawa M., Iikura M., Koketsu R., Nagase H., Tamura C., Komiya A., et al. An IL-1 cytokine member, IL-33, induces human basophil activation via its ST2 receptor. J Immunol 2008, 181:5981-5989.
10. Pecaric-Petkovic T., Didichenko S.A., Kaempfer S., Spiegl N., Dahinden C.A. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009, 113:1526-1534.
11. Cherry W.B., Yoon J., Bartemes K.R., Iijima K., Kita H. A novel IL-1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol 2008, 121:1484-1490.
12. Bourgeois E., Van L.P., Samson M., Diem S., Barra A., Roga S., et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. Eur J Immunol 2009, 39:1046-1055.
13. H2-type response. J Allergy Clin Immunol 2009, 123:1047-1054.
14. Liew F.Y., Pitman N.I., McInnes I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010, 10:103-110.
15. Pushparaj P.N., Tay H.K., H'ng S.C., Pitman N., Xu D., McKenzie A., et al. The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci USA 2009, 106:9773-9778.
16. Préfontaine D., Lajoie-Kadoch S., Foley S., Audusseau S., Olivenstein R., Halayko A.J., et al. Increased expression of IL-33 in severe asthma: evidence of expression by airway smooth muscle cells. J Immunol 2009, 183:5094-5103.
17. Préfontaine D., Nadigel J., Chouiali F., Audusseau S., Semlali A., Chakir J., et al. Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010, 125:752-754.
18. Smith D.E. IL-33: a tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy 2010, 40:200-208.
19. Hayakawa H., Hayakawa M., Kume A., Tominaga S. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 2007, 282:26369-26380.
20. Kondo Y., Yoshimoto T., Yasuda K., Futatsugi-Yumikura S., Morimoto M., Hayashi N., et al. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol 2008, 20:791-800.
21. Matsuyama Y., Okazaki H., Tamemoto H., Kimura H., Kamata Y., Nagatani K., et al. Increased levels of interleukin 33 in sera and synovial fluid from patients with active rheumatoid arthritis. J Rheumatol 2010, 37:18-25.
22. Kobori A., Yagi Y., Imaeda H., Ban H., Bamba S., Tsujikawa T., et al. Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 2010, 45:999-1007.
23. Manetti M., Ibba-Manneschi L., Liakouli V., Guiducci S., Milia A.F., Benelli G., et al. The IL-1-like cytokine IL-33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 2010, 69:598-605.
24. Rankin A.L., Mumm J.B., Murphy E., Turner S., Yu N., McClanahan T.K., et al. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol 2010, 184:1526-1535.
25. Miller A.M., Xu D., Asquith D.L., Denby L., Li Y., Sattar N., et al. IL-33 reduces the development of atherosclerosis. J Exp Med 2008, 205:339-346.
26. Alves-Filho J.C., Sônego F., Souto F.O., Freitas A., Verri W.A., Auxiliadora-Martins M., et al. Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection. Nat Med 2010, 16:708-712.
27. Lüthi A.U., Cullen S.P., McNeela E.A., Duriez P.J., Afonina I.S., Sheridan C., et al. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
28. Ohno T., Oboki K., Kajiwara N., Morii E., Aozasa K., Flavell R.A., et al. Caspase-1, caspase-8, and calpain are dispensable for IL-33 release by macrophages. J Immunol 2009, 183:7890-7897.
29. Nile C.J., Barksby E., Jitprasertwong P., Preshaw P.M., Taylor J.J. Expression and regulation of interleukin-33 in human monocytes. Immunology 2010, 130:172-180.
30. Hudson C.A., Christophi G.P., Gruber R.C., Wilmore J.R., Lawrence D.A., Massa P.T. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 2008, 84:631-643.
31. Sanada S., Hakuno D., Higgins L.J., Schreiter E.R., McKenzie A.N.J., Lee R.T. IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 2007, 117:1538-1549.
32. Cayrol C., Girard J.P. The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci USA 2009, 106:9021-9026.
33. Kouzaki H., Iijima K., Kobayashi T., O'Grady S.M., Kita H. The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-yype responses. J Immunol 2011, 186:4375-4387.
34. Hsu C.L., Neilsen C.V., Bryce P.J. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. PLoS One 2010, 5:e11944.
35. Wood I.S., Wang B., Trayhurn P. IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes. Biochem Biophys Res Commun 2009, 384:105-109.
36. Maier J.A., Statuto M., Ragnotti G. Endogenous interleukin 1α must be transported to the nucleus to exert its activity in human endothelial cells. Mol Cell Biol 1994, 14:1845-1851.
37. Mosley B., Urdal D.L., Prickett K.S., Larsen A., Cosman D., Conlon P.J., et al. The interleukin-1 receptor binds the human interleukin-1α precursor but not the interleukin-1β precursor. J Biol Chem 1987, 262:2941-2944.
38. Eigenbrod T., Park J.H., Harder J., Iwakura Y., Núñez G. Cutting edge: critical role for mesothelial cells in necrosis-induced inflammation through the recognition of IL-1α released from dying cells. J Immunol 2008, 181:8194-8198.
39. Talabot-Ayer D., Lamacchia C., Gabay C., Palmer G. Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem 2009, 284:19420-19426.
40. Zhao W., Hu Z. The enigmatic processing and secretion of interleukin-33. Cell Mol Immunol 2010, 7:260-262.
41. Sakashita M., Yoshimoto T., Hirota T., Harada M., Okubo K., Osawa Y., et al. Association of serum interleukin-33 level and the interleukin-33 genetic variant with Japanese cedar pollinosis. Clin Exp Allergy 2008, 38:1875-1881.
42. Hu Z.Q., Zhao W.H., Shimamura T., Galli S.J. Interleukin 4-triggered, STAT6-dependent production of a factor that induces mouse mast cell apoptosis. Eur J Immunol 2006, 36:1275-1284.
43. Hu Z.Q., Asano K., Seki H., Shimamura T. An essential role of prostaglandin E on mouse mast cell induction. J Immunol 1995, 155:2134-2142.
44. Hu Z.Q., Kobayashi K., Zenda N., Shimamura T. Tumor necrosis factor-α- and interleukin-6-triggered mast cell development from mouse spleen cells. Blood 1997, 89:526-533.
45. Lemaire I., Yang H., Cantin M.F., Lemaire S. Up-regulation of cytokine production in alveolar macrophages by histogranin, a novel endogenous pentadecapeptide. Immunol Lett 1994, 41:37-42.